切换语言

发展历史

Regulation within living organisms primarily involves the transcription of DNA into RNA and the translation of RNA into proteins. Nucleic acid drugs utilizing the siRNA pathway mainly function by inhibiting or degrading endogenous mRNA to reduce protein expression levels. In contrast, nucleic acid drugs in the form of mRNA achieve therapeutic goals by introducing exogenous mRNA to induce the overexpression of specific proteins.

  • 研发周期短

    可通过少至数周时间修改mRNA序列适应新病原体或疾病靶点,尤其在应对突发传染病或高突变率病原体时优势明显

  • 生物安全性高

    mRNA不进入细胞核,也无法整合到宿主基因组DNA上

  • 半衰期短

    代谢产物为天然核苷酸,无长期风险

  • 免疫激活能力强

    可诱导细胞免疫和体液免疫双重反应,适用于疫苗和免疫治疗

  • 传染病疫苗

  • 癌症疫苗

  • 免疫治疗

  • 肿 瘤

  • 代谢疾病

  • 罕见病

地 址:3rd Floor, Building B3, No. 88 Dongchang Road (2.5 Industrial Park), Suzhou Industrial Park

电 话:0512-66033978

邮 箱:hlsw@healrna.com

Copyright © 2020-2021 Healrna. All Rights Reserved. 苏ICP备16273928号